---
title: "Medication Management Protocol"
description: "Standard procedures for medication management at Adapt Psychiatry"
lastUpdated: "2024-01-15"
author: "Clinical Team"
section: "clinical"
access: "all"
readingTime: "8 min"
---

## Overview

This protocol outlines the standard procedures for medication management at Adapt Psychiatry. All prescribing clinicians must follow these guidelines to ensure safe, effective, and compliant care.

## Initial Assessment

### Before Prescribing

Complete the following before initiating any new medication:

1. **Comprehensive psychiatric evaluation**
   - Document current symptoms and severity
   - Assess functional impairment
   - Review past psychiatric history

2. **Medical history review**
   - Current medications (including OTC and supplements)
   - Allergies and adverse reactions
   - Medical conditions that may affect medication choice

3. **Substance use assessment**
   - Current use patterns
   - History of substance use disorders
   - Potential drug interactions

4. **Contraindication screening**
   - Check for absolute contraindications
   - Assess relative contraindications
   - Consider pregnancy/lactation status

5. **Informed consent discussion**
   - Benefits of proposed treatment
   - Potential risks and side effects
   - Alternative treatment options
   - Document discussion in patient record

### Required Documentation

Every new prescription must include:

- **Diagnosis** with supporting DSM-5 criteria
- **Target symptoms** for medication treatment
- **Previous medication trials** and responses
- **Patient preferences and concerns**
- **Risk assessment** (suicide, self-harm, violence)

## Follow-Up Schedule

| Medication Type | Initial Follow-Up | Ongoing Monitoring |
|-----------------|-------------------|-------------------|
| New antidepressant | 2-4 weeks | Every 3 months |
| Mood stabilizer | 1-2 weeks | Monthly for 3 months, then every 3 months |
| Stimulant | 1 week | Monthly |
| Antipsychotic | 1-2 weeks | Every 3 months |
| Anxiolytic (short-term) | 1-2 weeks | Weekly during taper |

## Side Effect Monitoring

### Common Side Effects to Assess

**Antidepressants (SSRIs/SNRIs):**
- Gastrointestinal upset (nausea, diarrhea)
- Sleep changes (insomnia or sedation)
- Sexual side effects
- Activation/akathisia

**Mood Stabilizers:**
- Tremor
- Weight gain
- Cognitive effects
- Gastrointestinal symptoms

**Stimulants:**
- Appetite suppression
- Sleep disturbance
- Anxiety/irritability
- Cardiovascular effects

**Antipsychotics:**
- Weight gain
- Metabolic changes
- Extrapyramidal symptoms
- Sedation

### Documentation Requirements

At each follow-up visit, document:

- [ ] Medication adherence (patient report + pharmacy records if available)
- [ ] Side effects present (use structured inquiry)
- [ ] Efficacy assessment (target symptom improvement)
- [ ] Any dose adjustments made
- [ ] Patient's subjective response to treatment

## Refill Policies

### Controlled Substances

- **Schedule II:** New prescription required each fill
- **Schedule III-V:** Maximum 5 refills within 6 months
- **Appointment required:** Within 30 days of last visit
- **PDMP check:** Required before each prescription

### Non-Controlled Medications

- May provide up to 90-day supply for stable patients
- Early refill requests require clinical review
- Document reason for any early refill

### Lost Medication Policy

- One-time replacement per year for non-controlled substances
- Controlled substances: case-by-case basis with documentation
- Patient responsible for replacement cost

## Emergency Protocols

### Suicidal Ideation

1. **Assess risk level** using Columbia Scale
2. **Consider hospitalization** if high risk
3. **Document safety plan** in patient record
4. **Increase follow-up frequency** (within 1 week)
5. **Consider medication changes** if related to treatment

### Severe Adverse Reactions

1. **Discontinue medication immediately** if severe
2. **Provide appropriate treatment** for adverse effect
3. **Document reaction** in patient record and allergy list
4. **Follow up within 24-48 hours**
5. **Report** to FDA MedWatch if indicated

## Special Populations

### Pediatric Patients

- Start at lower doses
- More frequent monitoring
- Involve parents/guardians in medication management
- Consider growth and development impact

### Geriatric Patients

- "Start low, go slow" principle
- Monitor for cognitive effects
- Assess fall risk
- Review for drug-drug interactions

### Pregnant Patients

- Consult with OB/GYN
- Use lowest effective dose
- Consider risks vs. benefits
- Document informed consent

## Resources

- [APA Practice Guidelines](https://psychiatry.org/psychiatrists/practice/clinical-practice-guidelines)
- [FDA Medication Guides](https://www.fda.gov/drugs/drug-safety-and-availability/medication-guides)
- Clinical pharmacology references

## Questions?

Contact the Clinical Director for medication management questions or concerns.
